Aquatic Capital Management LLC Acquires New Position in UnitedHealth Group Incorporated (NYSE:UNH)

Aquatic Capital Management LLC acquired a new stake in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) in the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor acquired 75,543 shares of the healthcare conglomerate's stock, valued at approximately $38,214,000. UnitedHealth Group makes up approximately 1.0% of Aquatic Capital Management LLC's investment portfolio, making the stock its 6th largest position.

A number of other institutional investors also recently made changes to their positions in UNH. NewSquare Capital LLC bought a new position in UnitedHealth Group in the 4th quarter worth $25,000. Hurley Capital LLC purchased a new stake in shares of UnitedHealth Group during the fourth quarter valued at $28,000. Aster Capital Management DIFC Ltd bought a new position in UnitedHealth Group during the 4th quarter valued at about $30,000. AlphaMark Advisors LLC bought a new stake in shares of UnitedHealth Group in the fourth quarter worth approximately $30,000. Finally, Promus Capital LLC purchased a new stake in UnitedHealth Group in the fourth quarter worth approximately $32,000. Hedge funds and other institutional investors own 87.86% of the company's stock.

UnitedHealth Group Price Performance

NYSE:UNH traded up $0.43 during trading hours on Wednesday, reaching $409.66. 4,390,441 shares of the company were exchanged, compared to its average volume of 4,521,430. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. The stock's 50-day moving average is $499.59 and its 200-day moving average is $532.08. The firm has a market cap of $372.88 billion, a PE ratio of 26.43, a price-to-earnings-growth ratio of 1.37 and a beta of 0.61. UnitedHealth Group Incorporated has a twelve month low of $401.28 and a twelve month high of $630.73.

UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its quarterly earnings data on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share for the quarter, missing analysts' consensus estimates of $7.29 by ($0.09). The company had revenue of $109.58 billion for the quarter, compared to analyst estimates of $111.56 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. During the same quarter in the prior year, the company posted $6.91 earnings per share. On average, sell-side analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, March 18th. Investors of record on Monday, March 10th were issued a $2.10 dividend. This represents a $8.40 dividend on an annualized basis and a dividend yield of 2.05%. The ex-dividend date was Monday, March 10th. UnitedHealth Group's dividend payout ratio is currently 35.18%.

Wall Street Analyst Weigh In

UNH has been the topic of a number of research reports. Raymond James restated a "strong-buy" rating and issued a $540.00 price target (down from $635.00) on shares of UnitedHealth Group in a research note on Monday, April 21st. Royal Bank of Canada reduced their price target on UnitedHealth Group from $655.00 to $525.00 and set an "outperform" rating for the company in a research report on Wednesday, April 23rd. Wells Fargo & Company reduced their target price on shares of UnitedHealth Group from $694.00 to $660.00 and set an "overweight" rating for the company in a report on Tuesday, January 28th. HSBC reissued a "hold" rating and issued a $490.00 price objective on shares of UnitedHealth Group in a research note on Tuesday, April 22nd. Finally, Cantor Fitzgerald restated an "overweight" rating and issued a $700.00 price objective on shares of UnitedHealth Group in a research report on Friday, January 17th. Three research analysts have rated the stock with a hold rating, nineteen have assigned a buy rating and three have issued a strong buy rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of "Buy" and a consensus target price of $596.86.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.